ASND · Ascendis Pharma A/S

$247.91 -1.45 (-0.58%) At close · Aug 28

Russell 1000 member Rebalance outlook locked

Market Cap

$16.26B

65.59M

Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.

Insider Sentiment Score

Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.

Net buyers

Net shares bought

0.00%

Net buy value

+$514,554

Date	Insider	Role	Type	Security	Shares	Price	Value	After
2026-08-14	BIENAIME JEAN JACQUES	Director	Buy↑ Filing footnotes — Ordinary Shares (Direct) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $245.41 to $246.30 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.	Ordinary Shares	1,100	$245.85	$270,435	2,000
2026-08-14	BIENAIME JEAN JACQUES	Director	Buy↑ Filing footnotes — Ordinary Shares (Direct) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $246.48 to $247.32 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.	Ordinary Shares	900	$246.91	$222,219	2,900
2026-06-02	SMITH SCOTT THOMAS	EVP & Chief Financial Officer	Buy↑	Ordinary Shares	100	$219.00	$21,900	4,367
2026-05-29	BIENAIME JEAN JACQUES	Director	Buy↑	Ordinary Shares	200	$223.76	$44,752	600
2026-05-29	BIENAIME JEAN JACQUES	Director	Buy↑	Ordinary Shares	200	$222.30	$44,460	800
2026-05-29	BIENAIME JEAN JACQUES	Director	Buy↑	Ordinary Shares	100	$223.50	$22,350	900
2026-05-29	SMITH SCOTT THOMAS	EVP & Chief Financial Officer	Buy↑	Ordinary Shares	250	$223.32	$55,830	4,267
2026-05-26	BIENAIME JEAN JACQUES	Director	Buy↑ Filing footnotes — Ordinary Shares (Direct) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $239.245 to $239.490 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.	Ordinary Shares	200	$239.37	$47,874	400
2026-05-26	BIENAIME JEAN JACQUES	Director	Buy↑ Filing footnotes — Ordinary Shares (Direct) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $235.93 to $236.54 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.	Ordinary Shares	200	$236.24	$47,247	200
2026-05-11	JENSEN FLEMMING STEEN	See Remarks	Sell↓	Ordinary Shares	19,460	$238.49	$4,641,021	0

Legend Buy — open-market purchase Sell — open-market sale ↑ Shares acquired ↓ Shares disposed (gift, conversion, tax…)

Showing 1–10 of 10 transactions

Key facts CIK 1612042 CUSIP K08588103 13F (30d) 285 filings 267 filers Visit website Investor relations